|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 185,100.00 KRW | -0.22% |
|
+2.32% | -1.28% |
| 01-09 | Celltrion to Unveil Drug Development Plans at JP Morgan Conference | MT |
| 12-27 | Celltrion, Inc. announces an Equity Buyback for 546,747 shares. | CI |
Celltrion, Inc. (KOSE:A068270) announces a share repurchase program. Under the program, the company will repurchase up to 537,924 shares. The purpose of the program is to stabilize stock prices and enhance shareholder value.
The program will expire on January 27, 2025. As of October 24, 2024, the company had 6,091,510 shares within the range of distributable profits and 4,834,777 shares in treasury.
